Lucas Biomedical

Lucas Biomedical is a clinical-stage biotechnology company based in Beijing, China, specializing in the development of regenerative medicine and cell-based therapies. The company's core focus is on the therapeutic application of umbilical cord-derived mesenchymal stem cells (UC-MSCs) for treating chronic and inflammatory diseases. Its lead clinical programs target liver cirrhosis and graft-versus-host disease (GVHD), with additional research exploring treatments for autoimmune conditions like systemic lupus erythematosus. Lucas Biomedical operates a comprehensive platform that includes cell isolation, expansion, and cryopreservation, supported by a state-of-the-art manufacturing facility. The company collaborates with leading hospitals and research institutions in China to advance its pipeline through clinical validation.